LncRNAs Landscape in the patients of primary gout by microarray analysis.

To determine the expression profile and clinical significance of long non-coding RNAs (lncRNAs) in peripheral blood mononuclear cells (PBMCs) of patients with primary gout and healthy control subjects. Human lncRNA microarrays were used to identify the differentially expressed lncRNAs and mRNAs in p...

Full description

Bibliographic Details
Main Authors: Yu-Feng Qing, Jian-Xiong Zheng, Yi-Ping Tang, Fei Dai, Zeng-Rong Dong, Quan-Bo Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0232918
_version_ 1819003486889574400
author Yu-Feng Qing
Jian-Xiong Zheng
Yi-Ping Tang
Fei Dai
Zeng-Rong Dong
Quan-Bo Zhang
author_facet Yu-Feng Qing
Jian-Xiong Zheng
Yi-Ping Tang
Fei Dai
Zeng-Rong Dong
Quan-Bo Zhang
author_sort Yu-Feng Qing
collection DOAJ
description To determine the expression profile and clinical significance of long non-coding RNAs (lncRNAs) in peripheral blood mononuclear cells (PBMCs) of patients with primary gout and healthy control subjects. Human lncRNA microarrays were used to identify the differentially expressed lncRNAs and mRNAs in primary gout patients (n = 6) and healthy control subjects (n = 6). Bioinformatics analyses were performed to predict the roles of differently expressed lncRNAs and mRNAs. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to detect the expression levels of 8 lnRNAs in 64 primary gout patients and 32 healthy control subjects. Spearman's correlation was used to analyze the correlation between these eight lncRNAs and the laboratory values of gout patients. A receiver operating characteristic (ROC) curve was constructed to evaluate the diagnostic value of the lncRNAs identified in gout. The microarray analysis identified 1479 differentially expressed lncRNAs (879 more highly expressed and 600 more lowly expressed), 862 differentially expressed mRNAs (390 more highly expressed and 472 more lowly expressed) in primary gout (fold change > 2, P < 0.05), respectively. The bioinformatic analysis indicated that the differentially expressed lncRNAs regulated the abnormally expressed mRNAs, which were involved in the pathogenesis of gout through several different pathways. The expression levels of TCONS_00004393 and ENST00000566457 were significantly increased in the acute gout flare group than those in the intercritical gout group or healthy subjects (P<0.01). Moreover, inflammation indicators were positive correlated with TCONS_00004393 and ENST00000566457 expression levels. The areas under the ROC curve of ENST00000566457 and NR-026756 were 0.868 and 0.948, respectively. Our results provide novel insight into the mechanisms of primary gout, and reveal that TCONS_00004393 and ENST00000566457 might be as candidate targets for the treatment of gout flare; ENST00000566457 and NR-026756 could effectively discriminate between the gout and the healthy control groups.
first_indexed 2024-12-20T23:21:46Z
format Article
id doaj.art-62ace0679fa648a1bd7e25fc51e6bb09
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T23:21:46Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-62ace0679fa648a1bd7e25fc51e6bb092022-12-21T19:23:30ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01162e023291810.1371/journal.pone.0232918LncRNAs Landscape in the patients of primary gout by microarray analysis.Yu-Feng QingJian-Xiong ZhengYi-Ping TangFei DaiZeng-Rong DongQuan-Bo ZhangTo determine the expression profile and clinical significance of long non-coding RNAs (lncRNAs) in peripheral blood mononuclear cells (PBMCs) of patients with primary gout and healthy control subjects. Human lncRNA microarrays were used to identify the differentially expressed lncRNAs and mRNAs in primary gout patients (n = 6) and healthy control subjects (n = 6). Bioinformatics analyses were performed to predict the roles of differently expressed lncRNAs and mRNAs. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to detect the expression levels of 8 lnRNAs in 64 primary gout patients and 32 healthy control subjects. Spearman's correlation was used to analyze the correlation between these eight lncRNAs and the laboratory values of gout patients. A receiver operating characteristic (ROC) curve was constructed to evaluate the diagnostic value of the lncRNAs identified in gout. The microarray analysis identified 1479 differentially expressed lncRNAs (879 more highly expressed and 600 more lowly expressed), 862 differentially expressed mRNAs (390 more highly expressed and 472 more lowly expressed) in primary gout (fold change > 2, P < 0.05), respectively. The bioinformatic analysis indicated that the differentially expressed lncRNAs regulated the abnormally expressed mRNAs, which were involved in the pathogenesis of gout through several different pathways. The expression levels of TCONS_00004393 and ENST00000566457 were significantly increased in the acute gout flare group than those in the intercritical gout group or healthy subjects (P<0.01). Moreover, inflammation indicators were positive correlated with TCONS_00004393 and ENST00000566457 expression levels. The areas under the ROC curve of ENST00000566457 and NR-026756 were 0.868 and 0.948, respectively. Our results provide novel insight into the mechanisms of primary gout, and reveal that TCONS_00004393 and ENST00000566457 might be as candidate targets for the treatment of gout flare; ENST00000566457 and NR-026756 could effectively discriminate between the gout and the healthy control groups.https://doi.org/10.1371/journal.pone.0232918
spellingShingle Yu-Feng Qing
Jian-Xiong Zheng
Yi-Ping Tang
Fei Dai
Zeng-Rong Dong
Quan-Bo Zhang
LncRNAs Landscape in the patients of primary gout by microarray analysis.
PLoS ONE
title LncRNAs Landscape in the patients of primary gout by microarray analysis.
title_full LncRNAs Landscape in the patients of primary gout by microarray analysis.
title_fullStr LncRNAs Landscape in the patients of primary gout by microarray analysis.
title_full_unstemmed LncRNAs Landscape in the patients of primary gout by microarray analysis.
title_short LncRNAs Landscape in the patients of primary gout by microarray analysis.
title_sort lncrnas landscape in the patients of primary gout by microarray analysis
url https://doi.org/10.1371/journal.pone.0232918
work_keys_str_mv AT yufengqing lncrnaslandscapeinthepatientsofprimarygoutbymicroarrayanalysis
AT jianxiongzheng lncrnaslandscapeinthepatientsofprimarygoutbymicroarrayanalysis
AT yipingtang lncrnaslandscapeinthepatientsofprimarygoutbymicroarrayanalysis
AT feidai lncrnaslandscapeinthepatientsofprimarygoutbymicroarrayanalysis
AT zengrongdong lncrnaslandscapeinthepatientsofprimarygoutbymicroarrayanalysis
AT quanbozhang lncrnaslandscapeinthepatientsofprimarygoutbymicroarrayanalysis